SBH
ERB

Segall Bryant & Hamill’s ERBA DIAGNOSTICS ERB Stock Holding History

Segall Bryant & Hamill’s Portfolio ERB Stock Details ERB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,000
Closed -$12K – 572
2016
Q1 		$12K Hold
12,000
– – ﹤0.01% 544
2015
Q4 		$17K Hold
12,000
– – ﹤0.01% 529
2015
Q3 		$23K Hold
12,000
– – ﹤0.01% 540
2015
Q2 		$26K Buy
+12,000
New +$35.7K ﹤0.01% 550
2014
Q2 		– Sell
-11,250
Closed -$29K – 589
2014
Q1 		$29K Sell
11,250
-8,750
-44% -$25.8K ﹤0.01% 573
2013
Q4 		$55K Buy
20,000
+10,000
+100% +$19K ﹤0.01% 580
2013
Q3 		$14K Buy
+10,000
New +$9.75K ﹤0.01% 569

Other funds holding ERB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Segall Bryant & Hamill's ERB Position: Q2 2016 in Review

Segall Bryant & Hamill sold out of ERBA DIAGNOSTICS (ERB) in Q2 2016, closing a stake of 12,000 shares — an estimated $12K sold.

Segall Bryant & Hamill first reported a position in ERB in Q3 2013 and held it in 7 quarters. The position peaked at $55K in Q4 2013. 12 funds tracked by Wall St. Rank hold ERB as of Q2 2016.

  • Segall Bryant & Hamill reported no remaining ERBA DIAGNOSTICS position as of Q2 2016 after selling out during the quarter.
  • Segall Bryant & Hamill sold 12,000 ERBA DIAGNOSTICS shares in Q2 2016, an estimated $12K.
  • Segall Bryant & Hamill first reported a position in ERBA DIAGNOSTICS in Q3 2013 and held it in 7 quarters.
  • Segall Bryant & Hamill's ERBA DIAGNOSTICS position peaked at $55K in Q4 2013.
  • 12 funds tracked by Wall St. Rank held ERBA DIAGNOSTICS as of Q2 2016.

Based on Segall Bryant & Hamill's 13F filing for Q2 2016, filed 10 Aug 2016.